ArticleJCO precision oncology2023

Benchmarking Outcomes for Molecularly Characterized Synchronous Oligometastatic Non-Small-Cell Lung Cancer Reveals

Brian De et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.